Threshold Pharmaceuticals Achieves Target Enrollment in Phase III Sarcoma Trial

barbara.lempert Threshold Pharmaceuticals Announces Target Enrollment of 620 Patients Achieved in Pivotal Phase 3 Trial of TH-302 in Advanced Soft Tissue Sarcoma $ 12.5 Million USD ...

TiGenix snags $13.7M for Phase III cell therapy

Damian Garde Belgium's TiGenix has hauled in about $ 13.7 million in debt financing, piling up cash as it works through Phase III with a stem cell treatment. FierceBiotech News

OncoNova Discontinues Phase III Pancreatic Cancer Trial

barbara.lempert Onconova Announces Results of Interim Analysis of Metastatic Pancreatic Cancer Study NEWTOWN, Pa., Dec. 17, 2013 (GLOBE NEWSWIRE) — Onconova Therapeutics, Inc. ...

Immunocore Starts Phase IIa Trial for Melanoma

mia.burns Immunocore initiates Phase IIa clinical trial for IMCgp100 in melanoma (Oxford, UK, 31 October 2013) Immunocore Limited, the Oxford-based biotechnology company developing ...

CEVEC Completes Phase I Trial

mia.burns Completion of a “First in Human” Clinical Phase I Study with a Therapeutic Protein Derived from CAP® Cells Cologne, Germany, November 1, 2013 / B3C newswire / – ...

Phase IIb BMS Arthritis Drug Meets Endpoint

barbara.lempert Promising Phase IIb Data On Clazakizumab In Patients With Moderate-To-Severe Rheumatoid Arthritis To Be Presented At The 2013 Annual Meeting Of The American ...

First Patient Enrolled in Phase III Trial Evaluating The Medicines Company’s Angiomax

barbara.lempert First Patient Enrolled in Phase III Trial Evaluating The Medicines Company’s Angiomax(R) (Bivalirudin) in Patients Undergoing Peripheral Endovascular ...

Nektar Phase II Trial for NKTR-181 Misses Primary Endpoint

mia.burns Nektar Announces Preliminary Topline Results from Phase 2 Efficacy Study for NKTR-181 in Chronic Pain Patients with Osteoarthritis of the Knee Company to Host Conference ...

Ariad Reaches 50 Percent Patient Enrollment in Phase 3 Epic Trial of Iclusig

barbara.lempert Interim Analysis of Efficacy in Newly Diagnosed Patients With Chronic Myeloid Leukemia Expected in Third Quarter of 2014   Cambridge, MA—September 4, 2013 – ...

Debiopharm Group initiates phase I dose escalation study

barbara.lempert With Debio 1347 (CH5183284) in advanced solid tumors with FGFR alterations Lausanne, Switzerland – September 2nd, 2013 – Debiopharm Group™ (Debiopharm), the ...

Lipidor reports positive clinical Phase I/II data in psoriasis

barbara.lempert STOCKHOLM – August 27, 2013. Today Lipidor announced positive results from a Phase I/IIa study investigating the efficacy and tolerability of its AKVANO®/calcipotriol ...

Final Patient Finishes in Prosonix Phase II Trial for COPD

mia.burns Final Patient Completes Prosonix’ Phase 2 Clinical Study with PSX1002 in Moderate to Severe Chronic Obstructive Pulmonary Disease (COPD) OXFORD, England, August 16, ...
Page 4 of 11« First...23456...10...Last »
© 2018 Global Regulatory Science. All rights reserved. Site Admin · Entries RSS · Comments RSS